Pfizer (PFE) announced that James List has joined the company as Chief Internal Medicine Officer. List will oversee Pfizer’s Internal Medicine ...

Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...

A month has gone by since the last earnings report for Pfizer (PFE). Shares have lost about 1.9% in that time frame, outperforming the S&P 500. Will the recent negative trend continue leading up to ...

The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.

Drugs in late-stage development may mean competition on price for two Pfizer medications that, by some accounts, are the most expensive cardiac medications in history.

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...

A German court ruled that BioNTech (BNTX) and Pfizer (PFE) have to pay Moderna damages because they infringed on Moderna ...

The market sentiment in the next few months is likely to be quite positive for Pfizer. Read why I maintain my strong buy ...

Jim Cramer remains optimistic about Pfizer’s CEO, Dr. Albert Bourla, despite the company’s struggles with debt and market volatility. Cramer highlighted how Pfizer is leveraging AI in its operations, ...

We recently compiled a list of the Jim Cramer Discusses These 11 Stocks & Shares ChatGPT’s Flaws. In this article, we are ...

Shrewd investors know that bear markets open up great opportunities to pick up shares of excellent companies from the ...

Bury's 'local plan' is being produced but massive housing projects planned for green land at areas such as Elton reservoir ...